Vaccine-Induced Immunity and Duration of Protection

Understanding vaccine-induced immunity and the duration of protection is critical for designing effective immunization strategies. Vaccine efficacy depends not only on the initial immune response but also on the persistence of protective antibodies and memory T and B cells. Research investigates factors that influence immune longevity, including antigen type, adjuvant selection, dosing intervals, age, genetic background, and comorbidities. Booster doses and heterologous vaccination strategies are explored to maintain immunity over time, particularly for pathogens with high mutation rates. Longitudinal studies and immunological profiling provide insights into the kinetics of immune responses, informing recommendations for revaccination and global vaccination schedules. Assessing correlates of protection helps predict population-level immunity and guides the development of next-generation vaccines with improved durability. This area of research is essential for preventing disease resurgence, optimizing vaccine strategies for special populations, and achieving long-term public health goals.

    Related Conference of Vaccine-Induced Immunity and Duration of Protection

    September 07-08, 2026

    38th Annual Congress on Vaccine and Clinical Trials

    London, UK
    September 21-22, 2026

    44th Euro Global Summit and Expo on Vaccines & Vaccination

    Barcelona, Spain
    November 16-17, 2026

    7th International Conference on Vaccine Research

    Tokyo, Japan

    Vaccine-Induced Immunity and Duration of Protection Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in